Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [Grupo de Estudio de Linfoproliferativos de Latino América (GELL)]

Luis Villelaa Facultad de Medicina, Universidad Autónoma de Sinaloa, Culiacán, Mexico;b Hospital Fernando Ocaranza ISSSTE, Hermosillo, Mexico;c Centro Médico “Dr. Ignacio Chávez” ISSSTESON, Hermosillo, MexicoCorrespondence[email protected]

https://orcid.org/0000-0001-8811-7913 View further author information

María Torre-Vierad Oncological Hematology Unit 360, Clínica Santa Sofía, Instituto de Oncología y Hematología, Universidad Central de Venezuela, Caracas, VenezuelaView further author information

Henry Idrobo-Quinteroe Hematology-Oncology Department, Universidad del Valle, Cali, ColombiaView further author information

Brady E. Beltranf Department of Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins and Research Center for Precision Medicine, Universidad San Martín de Porres Medical School, Lima, PeruView further author information

& on behalf of Grupo de Estudio de Linfoproliferativos de Latinoamérica (GELL)

Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [Grupo de Estudio de Linfoproliferativos de Latino América (GELL)]

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Non-Hodgkin lymphoma treatment in middle-income countries in Latin America: perspective of the Latin American Study Group of Lymphoproliferative Disorders [Grupo de Estudio de Linfoproliferativos de Latino América (GELL)]

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date